AKR1B10
Aldo-keto reductase family 1 member B10
Also known as: AK1BA_HUMAN, AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O60218
- Gene
- AKR1B10
- Ensembl
- ENSG00000198074
- Chromosome
- 7
- Canonical length
- 316 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Plasma membrane,Cytosol
- Secretome location
- Secreted to digestive system
OverviewNCBI Gene
This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. This member can efficiently reduce aliphatic and aromatic aldehydes, and it is less active on hexoses. It is highly expressed in adrenal gland, small intestine, and colon, and may play an important role in liver carcinogenesis. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
316 residues, UniProt reviewed canonical sequence.
>O60218|AKR1B10
1 MATFVELSTK AKMPIVGLGT WKSPLGKVKE AVKVAIDAGY RHIDCAYVYQ NEHEVGEAIQ
61 EKIQEKAVKR EDLFIVSKLW PTFFERPLVR KAFEKTLKDL KLSYLDVYLI HWPQGFKSGD
121 DLFPKDDKGN AIGGKATFLD AWEAMEELVD EGLVKALGVS NFSHFQIEKL LNKPGLKYKP
181 VTNQVECHPY LTQEKLIQYC HSKGITVTAY SPLGSPDRPW AKPEDPSLLE DPKIKEIAAK
241 HKKTAAQVLI RFHIQRNVIV IPKSVTPARI VENIQVFDFK LSDEEMATIL SFNRNWRACN
301 VLQSSHLEDY PFNAEYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AKR1B10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.22
- Highest tissue expression
- 578 nTPM
Expression across tissuesHPA
Tissue
- duodenum: 578 nTPM
- stomach: 408 nTPM
- small intestine: 334 nTPM
- esophagus: 211 nTPM
- gallbladder: 166 nTPM
- vagina: 137 nTPM
Single-cell type
- esophageal suprabasal cells: 880 nCPM
- foveolar cells: 853 nCPM
- esophageal basal cells: 569 nCPM
- suprabasal keratinocytes: 497 nCPM
- enterocytes: 304 nCPM
- basal keratinocytes: 226 nCPM
Immune cell
- basophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 1.5 nTPM
- pons: 1.2 nTPM
- cerebral cortex: 1.1 nTPM
- hippocampal formation: 1.1 nTPM
- spinal cord: 1.1 nTPM
- white matter: 1.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.31
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.19
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular detoxification of aldehyde
- daunorubicin metabolic process
- doxorubicin metabolic process
- farnesol catabolic process
- retinoid metabolic process
Molecular functions
- alcohol dehydrogenase (NADP+) activity
- aldose reductase (NADPH) activity
- all-trans-retinol dehydrogenase (NADP+) activity
- allyl-alcohol dehydrogenase activity
- geranylgeranyl reductase activity
- indanol dehydrogenase activity
- retinal dehydrogenase (NAD+) activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AKR1B10 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AKR1B10 as an antibody target. Whether an autoantibody or antibody against AKR1B10 could matter depends on whether native AKR1B10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AKR1B10 is annotated as secreted, so native AKR1B10 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label AKR1B10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...